CIK 0000086312
TRV TRAVELERS COMPANIES, INC.
Insider trading from SEC Form 4. Last filing Oct 31, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company
Signals
Open-market buys and sells at TRAVELERS COMPANIES, INC., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 30Weak | sell | BESSETTE ANDY F EVP and Chief Admin Officer | $1.1M | 4,520 | -21% | - |
Congressional trades
3 trades in TRV disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Julia Letlow House · R-LA | Purchase | TRV The Travelers Companies, Inc. Common Stock | $1,001 to $15k | Feb 20, 2026 | 20 days after the trade |
| Val T. Hoyle House · D-OR | Sale | TRV The Travelers Companies, Inc. Common Stock | $1,001 to $15k | Sep 23, 2025 | 17 days after the trade |
| Val T. Hoyle House · D-OR | Purchase | TRV The Travelers Companies, Inc. Common Stock | $1,001 to $15k | Oct 29, 2024 | 318 days after the trade |
Transactions
The last 4 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2024 | BESSETTE ANDY F EVP and Chief Admin Officer | GGift Common Stock | -42 | $0.00 | $0 | 16,934 | Oct 31, 2024 |
| Oct 28, 2024 | BESSETTE ANDY F EVP and Chief Admin Officer | MOption exercise Common Stock | +4,520 | $139.83 | $632k | 21,496 | Oct 30, 2024 |
| Oct 28, 2024 | BESSETTE ANDY F EVP and Chief Admin Officer | SOpen-market sale Common Stock | -4,520 | $253.46 | $1.1M | 16,976 | Oct 30, 2024 |
| Oct 28, 2024 | BESSETTE ANDY F EVP and Chief Admin Officer | MOption exercise Stock Options (Right to Buy)derivative | -4,520 | $0.00 | $0 | 0 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.